Clinical trial
A Retrospective Analysis of the Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's Disease
NCT06446219 is registered in ClinicalTrials.gov with Sixth Affiliated Hospital, Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Analysis of the Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's Disease
- Lead sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- March 31, 2024
- Enrollment
- 172 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.